BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA, Huang M, Wang KK, Hawk E. MicroRNA expression signatures during malignant progression from Barrett’s esophagus to esophageal adenocarcinoma. Cancer Prev Res (Phila). 2013;6:196-205. [PMID: 23466817 DOI: 10.1158/1940-6207.capr-12-0276] [Cited by in Crossref: 72] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Xie J, Tan ZH, Tang X, Mo MS, Liu YP, Gan RL, Li Y, Zhang L, Li GQ. miR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. World J Gastroenterol 2014; 20(46): 17439-17447 [PMID: 25516656 DOI: 10.3748/wjg.v20.i46.17439] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
2 Clark RJ, Craig MP, Agrawal S, Kadakia M. microRNA involvement in the onset and progression of Barrett's esophagus: a systematic review. Oncotarget 2018;9:8179-96. [PMID: 29487725 DOI: 10.18632/oncotarget.24145] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
3 Cabibi D, Caruso S, Bazan V, Castiglia M, Bronte G, Ingrao S, Fanale D, Cangemi A, Calò V, Listì A, Incorvaia L, Galvano A, Pantuso G, Fiorentino E, Castorina S, Russo A. Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus. Oncotarget 2016;7:47821-30. [PMID: 27374102 DOI: 10.18632/oncotarget.10291] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
4 Huang J, Zhang SY, Gao YM, Liu YF, Liu YB, Zhao ZG, Yang K. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell Prolif. 2014;47:277-286. [PMID: 24909356 DOI: 10.1111/cpr.12109] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
5 Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer 2014;120:3635-41. [PMID: 25091571 DOI: 10.1002/cncr.28911] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
6 Kestens C, Siersema PD, van Baal JW. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer. World J Gastroenterol 2016; 22(1): 1-7 [PMID: 26755856 DOI: 10.3748/wjg.v22.i1.1] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ma Z, Ma Y, Xia Q, Li Y, Li R, Chang W, Chen J, Leng Z, Tao K. MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1. J Cancer Res Clin Oncol. 2016;142:1201-1212. [PMID: 26955820 DOI: 10.1007/s00432-016-2139-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
8 Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA. Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol. 2013;10:643-655. [PMID: 24061039 DOI: 10.1038/nrclinonc.2013.170] [Cited by in Crossref: 249] [Cited by in F6Publishing: 243] [Article Influence: 27.7] [Reference Citation Analysis]
9 Sárközy M, Kahán Z, Csont T. A myriad of roles of miR-25 in health and disease. Oncotarget 2018;9:21580-612. [PMID: 29765562 DOI: 10.18632/oncotarget.24662] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
10 Mao Q, Quan T, Luo B, Guo X, Liu L, Zheng Q. MiR-375 targets KLF4 and impacts the proliferation of colorectal carcinoma. Tumour Biol 2016;37:463-71. [PMID: 26224477 DOI: 10.1007/s13277-015-3809-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
11 Wang N, Xu Z, Wang K, Zhu M, Li Y. Construction and analysis of regulatory genetic networks in cervical cancer based on involved microRNAs, target genes, transcription factors and host genes. Oncol Lett 2014;7:1279-83. [PMID: 24944708 DOI: 10.3892/ol.2014.1814] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
12 Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA. Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol. 2013;10:643-655. [PMID: 24061039 DOI: 10.1038/nrclinonc] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Shi ZC, Chu XR, Wu YG, Wu JH, Lu CW, Lü RX, Ding MC, Mao NF. MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA. Tumour Biol 2015;36:8579-84. [PMID: 26036761 DOI: 10.1007/s13277-015-3614-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
14 Chen W, Frankel WL, Cronley KM, Yu L, Zhou X, Yearsley MM. Significance of paneth cell metaplasia in Barrett esophagus: a morphologic and clinicopathologic study. Am J Clin Pathol. 2015;143:665-671. [PMID: 25873500 DOI: 10.1309/ajcpvujmcvbc9pkm] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
15 Kailasam A, Mittal SK, Agrawal DK. Epigenetics in the Pathogenesis of Esophageal Adenocarcinoma. Clin Transl Sci 2015;8:394-402. [PMID: 25388215 DOI: 10.1111/cts.12242] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
16 Greystoke A, Ayub M, Rothwell DG, Morris D, Burt D, Hodgkinson CL, Morrow CJ, Smith N, Aung K, Valle J, Carter L, Blackhall F, Dive C, Brady G. Development of a circulating miRNA assay to monitor tumor burden: From mouse to man. Mol Oncol 2016;10:282-91. [PMID: 26654130 DOI: 10.1016/j.molonc.2015.10.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
17 Huang YQ. Molecular mechanisms responsible for pathogenesis of Barrett's esophagus. Shijie Huaren Xiaohua Zazhi 2013; 21(34): 3813-3820 [DOI: 10.11569/wcjd.v21.i34.3813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Grady WM, Yu M, Markowitz SD, Chak A. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers. Cancer Epidemiol Biomarkers Prev 2020;29:2486-94. [PMID: 33093162 DOI: 10.1158/1055-9965.EPI-20-0223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wang L, Jiang J, Sun G, Zhang P, Li Y. Effects of lncRNA TUSC7 on the malignant biological behavior of osteosarcoma cells via regulation of miR-375. Oncol Lett 2020;20:133. [PMID: 32934702 DOI: 10.3892/ol.2020.11994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Sreedharan L, Mayne GC, Watson DI, Bright T, Lord RV, Ansar A, Wang T, Kist J, Astill DS, Hussey DJ. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett’s esophagus. World J Gastroenterol 2017; 23(30): 5508-5518 [PMID: 28852310 DOI: 10.3748/wjg.v23.i30.5508] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
21 Cook MB, Thrift AP. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance. Gastrointest Endosc Clin N Am 2021;31:1-26. [PMID: 33213789 DOI: 10.1016/j.giec.2020.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Radanova M, Mihaylova G, Mihaylova Z, Ivanova D, Tasinov O, Nazifova-Tasinova N, Pavlov P, Mirchev M, Conev N, Donev I. Circulating miR-618 Has Prognostic Significance in Patients with Metastatic Colon Cancer. Curr Oncol 2021;28:1204-15. [PMID: 33804070 DOI: 10.3390/curroncol28020116] [Reference Citation Analysis]
23 Li CY, Zhang WW, Xiang JL, Wang XH, Li J, Wang JL. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics. Chin Med J (Engl) 2019;132:2213-22. [PMID: 31490264 DOI: 10.1097/CM9.0000000000000427] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
24 Viswanathan V, Fields J, Boman BM. The miRNA23b-regulated signaling network as a key to cancer development--implications for translational research and therapeutics. J Mol Med (Berl) 2014;92:1129-38. [PMID: 25301113 DOI: 10.1007/s00109-014-1208-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
25 Matsuzaki J, Suzuki H. MicroRNAs in Barrett's esophagus: future prospects. Front Genet 2014;5:69. [PMID: 24765103 DOI: 10.3389/fgene.2014.00069] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
26 Drahos J, Schwameis K, Orzolek LD, Hao H, Birner P, Taylor PR, Pfeiffer RM, Schoppmann SF, Cook MB. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium. Cancer Epidemiol Biomarkers Prev 2016;25:429-37. [PMID: 26604271 DOI: 10.1158/1055-9965.EPI-15-0161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
27 Hwang J, Min BH, Jang J, Kang SY, Bae H, Jang SS, Kim JI, Kim KM. MicroRNA Expression Profiles in Gastric Carcinogenesis. Sci Rep 2018;8:14393. [PMID: 30258124 DOI: 10.1038/s41598-018-32782-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
28 Meng XR, Lu P, Mei JZ, Liu GJ, Fan QX. Expression analysis of miRNA and target mRNAs in esophageal cancer. Braz J Med Biol Res 2014;47:811-7. [PMID: 25098614 DOI: 10.1590/1414-431x20143906] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
29 Setién-Olarra A, Gainza-Cirauqui ML, Aguirre-Urizar JM, Marichalar-Mendia X. The role of microRNAs in oral lichenoid disorders. Systematic review. Med Oral Patol Oral Cir Bucal 2017;22:e548-53. [PMID: 28809371 DOI: 10.4317/medoral.21819] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Buas MF, Onstad L, Levine DM, Risch HA, Chow WH, Liu G, Fitzgerald RC, Bernstein L, Ye W, Bird NC, Romero Y, Casson AG, Corley DA, Shaheen NJ, Wu AH, Gammon MD, Reid BJ, Hardie LJ, Peters U, Whiteman DC, Vaughan TL. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium. PLoS One 2015;10:e0128617. [PMID: 26039359 DOI: 10.1371/journal.pone.0128617] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
31 Matsuzaki J, Suzuki H. Circulating microRNAs as potential biomarkers to detect transformation of Barrett's oesophagus to oesophageal adenocarcinoma. BMJ Open Gastroenterol 2017;4:e000160. [PMID: 29177063 DOI: 10.1136/bmjgast-2017-000160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
32 Edmonds MD, Eischen CM. Differences in miRNA expression in early stage lung adenocarcinomas that did and did not relapse. PLoS One 2014;9:e101802. [PMID: 25028925 DOI: 10.1371/journal.pone.0101802] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
33 Chiam K, Wang T, Watson DI, Mayne GC, Irvine TS, Bright T, Smith L, White IA, Bowen JM, Keefe D, Thompson SK, Jones ME, Hussey DJ. Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma. J Gastrointest Surg. 2015;19:1208-1215. [PMID: 25943911 DOI: 10.1007/s11605-015-2829-9] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 12.9] [Reference Citation Analysis]
34 Schrump DS. Invited commentary. Ann Thorac Surg 2014;97:1045. [PMID: 24580917 DOI: 10.1016/j.athoracsur.2013.12.031] [Reference Citation Analysis]
35 Chen X, Li B, Luo R, Cai S, Zhang C, Cao X. Analysis of the function of microRNA-375 in humans using bioinformatics. Biomed Rep 2017;6:561-6. [PMID: 28515914 DOI: 10.3892/br.2017.889] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
36 Neureiter D, Mayr C, Winkelmann P, Neumayer B, Klieser E, Wagner A, Hufnagl C, Emmanuel K, Holzinger J, Koch O, Kiesslich T, Varga M. Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center Experience. Cells 2020;9:E486. [PMID: 32093260 DOI: 10.3390/cells9020486] [Reference Citation Analysis]
37 Qi YR, Gao JX, Qian JY, Wang WJ, Jia WJ, Wang BM. Narrow-band imaging endoscopy for diagnosis of specialized intestinal metaplasia in Barrett's esophagus. Shijie Huaren Xiaohua Zazhi 2014; 22(3): 371-374 [DOI: 10.11569/wcjd.v22.i3.371] [Reference Citation Analysis]
38 Hezova R, Kovarikova A, Srovnal J, Zemanova M, Harustiak T, Ehrmann J, Hajduch M, Svoboda M, Sachlova M, Slaby O. Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus. Diagn Pathol 2015;10:42. [PMID: 25928282 DOI: 10.1186/s13000-015-0280-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
39 Maslyonkina KS, Konyukova AK, Alexeeva DY, Sinelnikov MY, Mikhaleva LM. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer Med 2021. [PMID: 34870375 DOI: 10.1002/cam4.4447] [Reference Citation Analysis]
40 Bennett M, Mashimo H. Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus. World J Gastrointest Pathophysiol 2014; 5(4): 438-449 [PMID: 25400987 DOI: 10.4291/wjgp.v5.i4.438] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
41 Guo Y, Yao B, Zhu Q, Xiao Z, Hu L, Liu X, Li L, Wang J, Xu Q, Yang L, Huang D. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4. J Cell Mol Med 2019;23:5037-47. [PMID: 31207037 DOI: 10.1111/jcmm.14361] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
42 Zhang X, Zhang Y, Liu X, Fang A, Li P, Li Z, Liu T, Yang Y, Du L, Wang C. MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin. PLoS One 2015;10:e0143441. [PMID: 26599571 DOI: 10.1371/journal.pone.0143441] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
43 Zarrilli G, Galuppini F, Angerilli V, Munari G, Sabbadin M, Lazzarin V, Nicolè L, Biancotti R, Fassan M. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma. Int J Mol Sci 2021;22:3640. [PMID: 33807389 DOI: 10.3390/ijms22073640] [Reference Citation Analysis]
44 Zhang HC, Tang KF. Clinical value of integrated-signature miRNAs in esophageal cancer. Cancer Med 2017;6:1893-903. [PMID: 28707457 DOI: 10.1002/cam4.1129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
45 Plum PS, Warnecke-Eberz U, Drebber U, Chon SH, Alakus H, Hölscher AH, Quaas A, Bruns CJ, Gockel I, Lorenz D, Metzger R, Bollschweiler E. Upregulation of miR-17-92 cluster is associated with progression and lymph node metastasis in oesophageal adenocarcinoma. Sci Rep 2019;9:12113. [PMID: 31431687 DOI: 10.1038/s41598-019-48624-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
46 Dong J, Liu Y, Liao W, Liu R, Shi P, Wang L. miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma. J Bone Oncol 2016;5:74-9. [PMID: 27335775 DOI: 10.1016/j.jbo.2016.05.001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
47 Garman KS, Owzar K, Hauser ER, Westfall K, Anderson BR, Souza RF, Diehl AM, Provenzale D, Shaheen NJ. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer. Dig Dis Sci. 2013;58:3178-3188. [PMID: 23925817 DOI: 10.1007/s10620-013-2806-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
48 Ding N, Maiuri AR, O'Hagan HM. The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases. Mutat Res Rev Mutat Res 2019;780:69-81. [PMID: 31395351 DOI: 10.1016/j.mrrev.2017.09.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
49 Ivanovic RF, Viana NI, Morais DR, Moura C, Silva IA, Leite KR, Pontes-Junior J, Nahas WC, Srougi M, Reis ST. miR-618: possible control over TIMP-1 and its expression in localized prostate cancer. BMC Cancer 2018;18:992. [PMID: 30340564 DOI: 10.1186/s12885-018-4930-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]